Does Cartilage-Hair Hypoplasia Affect Male Fertility?
At a Glance
Cartilage-hair hypoplasia (CHH) can impair male fertility by reducing sperm count and motility due to cell division defects in the testicles. Men with CHH can still build families using assisted reproductive technologies like IVF, but genetic counseling is highly recommended first.
In this answer
4 sections
Cartilage-hair hypoplasia (CHH) can affect male fertility, though much of the existing research has focused on female reproductive health [1][2]. While women with CHH typically have normal fertility and reproductive hormones, men with the condition may experience issues that make it more difficult to have biological children naturally [1][2]. These challenges are linked to the underlying RMRP gene mutation that causes CHH, which can impair rapid cell division within the testicles and may lead to reduced sperm count or motility [3][4][5]. However, there are established family-building options available, including working with a specialist in assisted reproduction and a genetic counselor [6][7].
Understanding Male Fertility in CHH
The underlying cause of CHH is a mutation in the RMRP gene. This gene provides instructions for making an essential piece of cellular machinery that controls how cells divide and grow [3][8]. While this mutation primarily affects cartilage (leading to short stature) and hair growth, it also impacts other systems that require rapid cell turnover, including the immune system [3][8].
Because producing healthy sperm requires continuous and rapid cell division, the RMRP mutation can cause a direct, intrinsic defect in how sperm develops within the testicles [4][5]. This is considered a primary testicular issue. As a result, men with CHH may experience:
- Oligospermia: A low sperm count in the semen.
- Azoospermia: A complete absence of sperm in the semen.
- Poor sperm motility: Sperm that have difficulty swimming to reach and fertilize an egg.
(Note: If you have read elsewhere that “CHH” causes a brain signaling issue called “hypogonadotropic hypogonadism,” be aware that this refers to a completely different condition—Congenital Hypogonadotropic Hypogonadism—which confusingly shares the exact same acronym [9][10]. In Cartilage-Hair Hypoplasia, the brain signaling is typically normal, but the testicles themselves struggle to produce sperm efficiently [9][3].)
Options for Family Building
Because the fertility challenges in Cartilage-Hair Hypoplasia stem from a primary cellular defect within the testicles rather than a hormonal signaling issue, hormonal treatments like gonadotropin therapy are typically ineffective. Instead, you will need to work with a reproductive endocrinologist (a fertility specialist) to explore other options.
Potential pathways include:
- Assisted Reproductive Technology (ART): If sperm are present but in very low numbers or with poor motility, specialized techniques can be used. A common approach is Intracytoplasmic Sperm Injection (ICSI), where a single healthy sperm is selected and injected directly into an egg during In Vitro Fertilization (IVF) [11]. If there is no sperm in the semen, minor surgical procedures might be used to retrieve sperm directly from the testicles.
- Alternative Family Building: Depending on your individual sperm analysis and personal preferences, you may also choose to explore options like using donor sperm or adoption.
The Importance of Genetic Counseling
Because Cartilage-Hair Hypoplasia is an inherited condition with potentially life-threatening immune problems, genetic counseling is an essential step before attempting to conceive [12][7].
CHH is an autosomal recessive condition, meaning both parents must pass on a mutated RMRP gene for a child to have the disease [12][13]. If you have CHH, you will pass one mutated gene to your child [12].
- If your partner does not carry the mutation, your child will be a carrier but will generally not have the disease [12][7].
- If your partner is a carrier, there is a high risk of your child having CHH [12][7].
A genetic counselor will strongly recommend that your partner undergo carrier screening for the RMRP mutation [12][7]. If your partner is a carrier, you have the option of using Preimplantation Genetic Testing (PGT-M) during IVF to test embryos for the condition before pregnancy [6][7].
Looking Ahead
Navigating fertility with CHH requires coordination between multiple specialists. Because CHH involves the immune system, it is crucial to have your comprehensive health and immune function evaluated by your primary care team before starting any intensive fertility treatments [14][15]. By proactively getting a baseline semen analysis and meeting with a genetic counselor, you and your partner can safely map out the best path forward for your family planning goals.
Common questions in this guide
Does Cartilage-Hair Hypoplasia cause male infertility?
Can hormone therapy fix fertility issues caused by CHH?
What are my options for having biological children if I have CHH?
Does my partner need genetic testing if I have Cartilage-Hair Hypoplasia?
Questions for Your Doctor
4 questions
- •Should I get a baseline semen analysis now to understand my fertility status, even if I'm not ready to start a family?
- •Does my partner need genetic carrier screening for the RMRP mutation before we try to conceive?
- •Are there any specific lifestyle modifications I should make to protect my current sperm function?
- •Is my immune system stable enough to safely proceed with fertility treatments if we choose to pursue IVF?
Questions for You
3 questions
- •How important is it to me to have a biologically related child versus exploring other family-building options like donor sperm or adoption?
- •At what age or life stage do I want to proactively begin testing my fertility?
- •Have I discussed the genetic risks of CHH and the possibility of needing IVF or preimplantation genetic testing with my partner?
References
References (15)
- 1
Gynecologic assessment of 19 adult females with cartilage-hair hypoplasia - high rate of HPV positivity.
Holopainen E, Vakkilainen S, Mäkitie O
Orphanet journal of rare diseases 2018; (13(1)):207 doi:10.1186/s13023-018-0945-9.
PMID: 30445974 - 2
Gynecologic health in cartilage-hair hypoplasia: A survey of 26 adult females.
Holopainen E, Vakkilainen S, Mäkitie O
American journal of medical genetics. Part A 2019; (179(2)):190-195 doi:10.1002/ajmg.a.60684.
PMID: 30561899 - 3
A disease-linked lncRNA mutation in RNase MRP inhibits ribosome synthesis.
Robertson N, Shchepachev V, Wright D, et al.
Nature communications 2022; (13(1)):649 doi:10.1038/s41467-022-28295-8.
PMID: 35115551 - 4
The human long non-coding RNA gene RMRP has pleiotropic effects and regulates cell-cycle progression at G2.
Vakkilainen S, Skoog T, Einarsdottir E, et al.
Scientific reports 2019; (9(1)):13758 doi:10.1038/s41598-019-50334-6.
PMID: 31551465 - 5
Defects in lymphocyte telomere homeostasis contribute to cellular immune phenotype in patients with cartilage-hair hypoplasia.
Aubert G, Strauss KA, Lansdorp PM, Rider NL
The Journal of allergy and clinical immunology 2017; (140(4)):1120-1129.e1 doi:10.1016/j.jaci.2016.11.051.
PMID: 28126377 - 6
Clinical Management of Congenital Hypogonadotropic Hypogonadism.
Young J, Xu C, Papadakis GE, et al.
Endocrine reviews 2019; (40(2)):669-710 doi:10.1210/er.2018-00116.
PMID: 30698671 - 7
Correlations Among Genotype and Outcome in Chinese Male Patients With Congenital Hypogonadotropic Hypogonadism Under HCG Treatment.
Chen Y, Sun T, Niu Y, et al.
The journal of sexual medicine 2020; (17(4)):645-657 doi:10.1016/j.jsxm.2020.01.011.
PMID: 32171629 - 8
Uncovering pathways regulating chondrogenic differentiation of CHH fibroblasts.
Chabronova A, van den Akker GGH, Meekels-Steinbusch MMF, et al.
Non-coding RNA research 2021; (6(4)):211-224 doi:10.1016/j.ncrna.2021.12.003.
PMID: 34988338 - 9
Parallel Multi-Gene Panel Testing for Diagnosis of Idiopathic Hypogonadotropic Hypogonadism/Kallmann Syndrome.
Senthilraja M, Chapla A, Jebasingh FK, et al.
Case reports in genetics 2019; (2019()):4218514 doi:10.1155/2019/4218514.
PMID: 31781422 - 10
Diversity of Pubertal Development in Cartilage-Hair Hypoplasia; Two Illustrative Cases.
Holopainen E, Vakkilainen S, Mäkitie O
Journal of pediatric and adolescent gynecology 2018; (31(4)):422-425 doi:10.1016/j.jpag.2018.02.128.
PMID: 29462708 - 11
Assisted reproductive techniques with congenital hypogonadotropic hypogonadism patients: a systematic review and meta-analysis.
Gao Y, Yu B, Mao J, et al.
BMC endocrine disorders 2018; (18(1)):85 doi:10.1186/s12902-018-0313-8.
PMID: 30453944 - 12
The Finnish founder mutation c.70 A>G in RMRP causes cartilage-hair hypoplasia in a Pakistani family.
Iqbal M, Muhammad N, Ali SA, et al.
Clinical dysmorphology 2017; (26(2)):121-123 doi:10.1097/MCD.0000000000000155.
PMID: 27740950 - 13
Familial cartilage-hair hypoplasia: prenatal ultrasound features and clinical outcomes in three siblings with identical RMRP variants.
Portela Carvalho C, Martins A, Alves I, Guedes-Martins L
BMJ case reports 2026; (19(2)) doi:10.1136/bcr-2025-267490.
PMID: 41720498 - 14
Lymphomas in cartilage-hair hypoplasia - A case series of 16 patients reveals advanced stage DLBCL as the most common form.
Kukkola HL, Utriainen P, Huttunen P, et al.
Frontiers in immunology 2022; (13()):1004694 doi:10.3389/fimmu.2022.1004694.
PMID: 36211439 - 15
[Cartilage-hair hypoplasia. A case report].
Staines-Boones TA, González-Villarreal MG, Hernández-Fernández C
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) 2019; (66(3)):379-383 doi:10.29262/ram.v66i3.561.
PMID: 31606024
This page provides educational information about male fertility in Cartilage-Hair Hypoplasia. It does not replace professional medical advice from your reproductive endocrinologist or genetic counselor.
Get notified when new evidence is published on Cartilage-hair hypoplasia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.